Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.715 USD | -0.55% | +2.48% | +15.73% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.73% | 334M | |
+9.51% | 115B | |
+11.92% | 106B | |
-3.17% | 21.96B | |
-14.25% | 21.87B | |
-5.29% | 19.21B | |
-3.88% | 18.08B | |
-38.29% | 17.71B | |
+6.64% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Truist Securities Upgrades Mersana Therapeutics to Buy From Hold, Price Target is $9